The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | R | Respiratory system | |
2 | R06 | Antihistamines for systemic use | |
3 | R06A | Antihistamines for systemic use | |
4 | R06AX | Other antihistamines for systemic use | |
5 | R06AX13 | Loratadine |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
Route | Amount |
---|---|
ORAL - Oral | 10 mg |
Active Ingredient | Description | |
---|---|---|
Loratadine |
Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage. |
Title | Information Source | Document Type | |
---|---|---|---|
CLARITYN ALLERGY Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CLARITYNE Syrup / Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
LORAPAED ALLERGY RELIEF Oral solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
LORATADINE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
LORYTEC Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
TICEVIS Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.